Hanin, Aurélie http://orcid.org/0000-0002-5912-9998
Demeret, Sophie
Lambrecq, Virginie
Rohaut, Benjamin
Marois, Clémence
Bouguerra, Meriem
Demoule, Alexandre
Beaudeux, Jean-Louis
Bittar, Randa
Denis, Jérôme Alexandre
Imbert-Bismut, Françoise
Lamari, Foudil
Rucheton, Benoit
Bonnefont-Rousselot, Dominique
Chavez, Mario http://orcid.org/0000-0003-0390-4833
Navarro, Vincent http://orcid.org/0000-0003-0077-8114
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-IAIHU-06)
Fondation pour la Recherche Médicale (FDM20170839111)
Fondation Assitance Publique-Hôpitaux de Paris (EPIRES- Marie Laure PLV Merchandising)
Article History
Received: 6 April 2022
Revised: 15 May 2022
Accepted: 16 May 2022
First Online: 29 June 2022
Declarations
:
: AH, SD, MC and VN have a patent pending related to the current research. VN reports personal fees from UCB Pharma, EISAI, GW Pharma and LivaNova, outside the submitted work. AD reports grants, personal fees and non-financial support from Philips and Lungpacer, personal fees from Baxter, Getinge, Lowenstein and Gilead, personal fees and non-financial support from Fisher & Paykel and Respinor and grants from French Ministry of Health, outside the submitted work. SD reports individual payment from UCB Pharma, Regeneron and ARGENX. The other authors report no disclosures related to the current research.
: The protocol was approved by our local (2012, CPP Paris-VI) and by the INSERM ethic committees (C16-16, 20152482). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Patients or relatives were informed and give their consent.
: Patients or relatives were informed and give their consent.